Comparison of the effects of unfractionated heparin and the low-molecular-weight heparins dalteparin and enoxaparin on spontaneous platelet aggregation and adenosine diphosphate activity in platelets during the third trimester of pregnancy

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 29, Issue 8, 2007, Pages 539-545

  Ajayi, A A Leslie ^a,b   Pharmacols, F B ^a   Cooper, J ^a   Horn, E H ^a   Rubin, P C ^a  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Adenosine diphosphate; Low molecular weight heparin; Pregnancy; Spontaneous platelet aggregation; Thrombosis; Unfractionated heparin; Whole blood

Indexed keywords

APYRASE; DALTEPARIN; ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; SODIUM CHLORIDE;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; ENZYME ACTIVITY; FEMALE; HUMAN; PREGNANT WOMAN; THIRD TRIMESTER PREGNANCY; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

ADENOSINE DIPHOSPHATE; ADULT; ANALYSIS OF VARIANCE; ANTICOAGULANTS; APYRASE; BLOOD PLATELETS; DALTEPARIN; ENOXAPARIN; FEMALE; HEPARIN; HUMANS; PLATELET AGGREGATION; PLATELET COUNT; PREGNANCY; PREGNANCY TRIMESTER, THIRD;

EID: 37149052445     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: 10.1358/mf.2007.29.8.1116308     Document Type: Article

References (24)

1. Fareed, J., Hoppensteadt, D., Walenga, J., Iqbal, O., Ma, Q., Jeske, W., Sheikh, T. Pharmacodynamic and pharmacokinetic properties of enoxaparin: Implications for clinical practice. Clin Pharmacokinet 2003, 42: 1043-57.
2. Hirsch, J., Levine, M.N. Low molecular weight heparins. Blood 1992, 79: 1-17.
3. Salzman, E.W. Low molecular weight heparin. Is small beautiful? N Engl J Med 1986, 315: 957-9.
4. Burgess-Wilson, M.E., Morrison, R., Heptinsall, S. Spontaneous platelet aggregation in heparinized blood during pregnancy. Thromb Res 1986, 37: 385-93.
5. Greer, I.A. Exploring the role of low molecular weight heparins in pregnancy. Sem Thromb Hemostat 2002, 28 (Suppl 3): 25-31.
6. Greer, I.A. Anticoagulants in pregnancy. J Thromb Thrombolysis 2006, 21: 57-65.
7. Horn, E.H. Platelets in normal and hypertensive pregnancy. Platelets 1991, 2: 183-95.
8. Ajayi, A.A., Horn, E.H., Rubin, P.C. Evidence of in vivo platelet activation during heparin anticoagulation in pregnancy for prophylaxis or treatment of thromboembolism. Afr J Med Med Sci 1999, 28: 113-15.
9. Burgess, J.K., Chong, B.H. The platelet pro-aggregating and potentiating effects of unfractionated heparin, low molecular weight heparin, and heparinoid in intensive care patients and healthy controls. Eur J Haematol 1997, 58: 279-85.
10. Storey, R.F., May, J.A., Heptinstall, S. Potentiation of platelet aggregation by heparin in human whole blood is attenuated by P2Y12 and P2Y1 antagonists but not aspirin. Thromb Res 2005, 115: 301-7.
11. Seshadri, N., Goldhaber, S.Z., Elkayam, U. et al. The clinical challenge of bridging anticoagulation with low molecular weight heparin in patients with mechanical prosthetic heart valves: An evidence based comparative review focusing on anticoagulation options in pregnant and non-pregnant patients. Am Heart J 2005, 150: 27-34.
12. Fox, S.C., Burgess-Wilson, M., Heptinstall, S., Mitchell, J.R.A. Platelet aggregation in whole blood using the Ultra-flo 100 platelet counter. Thromb Haemostat 1982, 48: 327-9.
13. Fox, S.C., Sasae, R., Janson, S., May, J.A., Heptinstall, S. Quantitation of platelet aggregation and microaggregate formation in whole blood by flow cytometry. Platelets 2004, 15: 85-93.
14. Saniabadi, A.R., Lowe, G.D., Barbenel, J.C., Forbes, C.D. A comparison of spontaneous platelet aggregation in whole blood with platelet rich plasma: Additional evidence for the role of ADP. Thromb Haemostat 1984, 51: 115-8.
15. Aggarwal, A., Whitaker, D.A., Rimmer, J.M. et al. Attenuation of platelet reactivity by enoxaparin compared with unfractionated heparin in patients undergoing hemodialysis. Nephrol Dial Transplant 2004, 19: 1559-63.
16. Klein, B., Faridi, A., von Tempelhoff, G.P., Heilmann, L., Mittermayer, C., Rath, W. A whole blood flow cytometric determination of platelet activation by unfractionated and low molecular weight heparin in vitro. Thromb Res 2002, 108: 291-6.
17. Holthe, M.R., Lyberg, T., Staff, A.C., Berge, L.N. Leucocyte-platelet interaction in pregnancies complicated with pre-eclampsia. Platelets 2005, 16: 91-7.
18. Furman, M.I., Kereiakes, D.J., Krueger, L.A. et al. Leukocyte-platelet aggregation, platelet surface P-selectin, and platelet surface glycoprotein IIIa after percutaneous coronary intervention: Effects of dalteparin or unfractionated heparin in combination with abciximab. Am Heart J 2001, 142: 790-8.
19. Hirsh, J., Rashke, R. Heparin and low-molecular-weight heparin. Chest 2004, 126: 188s-203s.
20. Holthe, M.R., Staff, A.C., Berge, L.N., Lyberg, T. Different levels of platelet activation in pre-eclamptic, normotensive pregnant, and non-pregnant women. Am J Obstet Gynecol 2004, 190: 1128-34.
21. Stafford, N.P., Pink, A.E., White, A.E., Glenn, J.R., Heptinstall, S. Mechanisms involved in adenosine triphosphate-induced platelet aggregation in whole blood. Arterioscler Thromb Vasc Biol 2003, 23: 1928-33.
22. Ahmad, S., Jeske, W.P., Walenga, J.M. et al. Synthetic pentasacharrides do not cause platelet activation by anti-heparin-platelet factor 4 antibodies. Clin Appl Thromb Hemost 1999, 5: 259-66.
23. Polgar, J., Eichler, P., Greinacher, A., Clemetson, K.J. Adenosine diphosphate (ADP) and ADP receptor play a major role in platelet activation/aggregation induced by sera from heparin-induced thrombocytopenia patients. Blood 1998, 91: 549-54.
24. ACOG Committee Opinion: Safety of lovenox in pregnancy. Obstet Gynecol 2002, 100: 845-6.